International Journal of Cardiology
Volume 131, Issue 2 , Pages 151-155 , 9 January 2009

Hypertrophic cardiomyopathy vs athlete's heart

Received 23 October 2008 ,Accepted 23 October 2008.

References 

  1. Maron BJ. Distinguishing hypertrophic cardiomyopathy from athlete's heart: a clinical problem of increasing magnitude and significance. Heart. 2005;91:1380–1382
  2. Cheng TO. The evolution of cardiology in China. In: Cardiothoracic surgery in China: past, present and future. Hong Kong: The Chinese University of Hong Kong; 2007;p. 204–305
  3. Tung CL, Hsieh CK, Bien CW, Dieuaide FR. The heart in ricksha pullers. A study of the effect of chronic exertion on the cardiovascular system. Am Heart J. 1934;10:79–100
  4. White PD. In: Heart disease. 4th Edition. New York: MacMillan Co.; 1951;p. 612
  5. Watkins H, Seidman CE, MacRae C, Seidman JG, McKenna W. Progress in familial hypertrophic cardiomyopathy: molecular genetic analyses in the original family studied by Teare. Br Heart J. 1992;67:34–38
  6. Teare D. Asymmetrical hypertrophy of the heart in young adults. Br Heart J. 1958;20:1–8
  7. Pelliccia A, Maron BJ, Spataro A, Proschan MA, Spirito P. The upper limit of physiologic cardiac hypertrophy in highly trained athletes. N Engl J Med. 1991;324:295–301
  8. Maron BJ, Gottdiener JS, Epstein SE. Patterns and significance of distribution of left ventricular hypertrophy in hypertrophic cardiomyopathy: a wide angle, two-dimensional echocardiographic study of 125 patients. Am J Cardiol. 1981;48:418–428
  9. Klues HG, Schiffers A, Maron BJ. Phenotypic spectrum and patterns of left ventricular hypertrophy in hypertrophic cardiomyopathy: morphologic observations and significance as assessed by two-dimensional echocardiography in 600 patients. J Am Coll Cardiol. 1995;26:1699–1708
  10. Spirito P, Pelliccia A, Proschan M, et al. Morphology of the “athlete's heart” assessed by echocardiography in 947 elite athletes representing 27 sports. Am J Cardiol. 1994;74:802–806
  11. Maron BJ. Hypertrophic cardiomyopathy: a systematic review. JAMA. 2002;287:1308–1320
  12. Maron BJ, Pelliccia A, Spirito P. Cardiac disease in young trained athletes: insights into methods for distinguishing athlete's heart from structural heart disease with particular emphasis on hypertrophic cardiomyopathy. Circulation. 1995;91:1596–1601
  13. Pelliccia A, Culasso F, Di Paolo FM, Maron BJ. Physiologic left ventricular cavity dilatation in elite athletes. Ann Intern Med. 1999;130:23–31
  14. Cheng TO. Hypertrophic cardiomyopathy evolving into a hypokinetic and dilated left ventricle: coronary embolization as a probable pathogenetic mechanism. Clin Cardiol. 1990;13(10):A31
  15. Pelliccia A, Avelar E, De Castro S, Pandian N. Global left ventricular shape is not altered as a consequence of physiologic remodeling in highly trained athletes. Am J Cardiol. 2000;86:700–702
  16. Shapiro LM, McKenna WJ. Distribution of left ventricular hypertrophy in hypertrophic cardiomyopathy: a two-dimensional echocardiographic study. J Am Coll Cardiol. 1983;2:437–444
  17. Pelliccia A, Maron BJ, Di Paolo FM, et al. Prevalence and clinical significance of left atrial remodeling in competitive athletes. J Am Coll Cardiol. 2005;46:690–696
  18. Nistri S, Olivotto I, Betocchi S, et al. Prognostic significance of left atrial size in patients with hypertrophic cardiomyopathy (from the Italian Registry for Hypertrophic Cardiomyopathy). Am J Cardiol. 2006;98:960–965
  19. Cheng TO. Prompt squatting and systolic murmurs. Am Heart J. 1969;77:433
  20. Cheng TO. Diagnostic tips in idiopathic hypertrophic subaortic stenosis. Hosp. Physician. 1982;18:36
  21. Cheng TO. Atypical HCM signs. Phys Sportsmed. 1995;23(7):21
  22. Cheng TO. Case of the month/cardiology: a 30-year-old athlete fell by syncope. Cortlandt Forum. 1998;11(4):217–229
  23. Cheng TO. Valsalva maneuver is not a held deep inspiration. Am J Cardiol. 2001;88:1219–1220
  24. Maron MS, Olivotto I, Zenovich AG, et al. Hypertrophic cardiomyopathy is predominantly a disease of left ventricular outflow tract obstruction. Circulation. 2006;114:2232–2239
  25. Shah JS, Tome Esteban MT, Thaman R, et al. Prevalence of exercise induced left ventricular outflow tract obstruction in symptomatic patients with non-obstructive hypertrophic cardiomyopathy. Heart. Oct. 21 2008;94:1288–1294
  26. Vaglio JC, Ommen SR, Nishimura RA, Tajik AJ, Gersh BJ. Clinical characteristics and outcomes of patients with hypertrophic cardiomyopathy with a latent obstruction. Am Heart J. 2008;156:342–347
  27. Griffet V, Guérard S, Galoisy-Guibal L, Caignault JR, Bernard F, Brion R. Normal values of the peak early diastolic Ea using myocardial tissue Doppler in 100 elite athletes. Arch Mal Coeur Vaiss. 2007;100:809–815
  28. Pelliccia A, Maron BJ. The athlete's heart, ECG, and differential diagnosis with hypertrophic cardiomyopathy and other cardiomyopathies. In:  Maron BJ editors. Diagnosis and management of hypertrophic cardiomyopathy. Malden, MA: Blackwell Futura; 2004;p. 367–381
  29. Krieg A, Scharhag J, Kindermann W, Urhausen A. Cardiac tissue Doppler imaging in sports medicine. Sports Med. 2007;37:15–30
  30. Zoncu S, Pelliccia A, Mercuro G. Assessment of regional systolic and diastolic wall motion velocities in highly trained athletes by pulsed wave Doppler tissue imaging. J Am Soc Echocardiogr. 2002;15:900–905
  31. D'Andrea A, D'Andrea L, Caso P, Scherillo M, Zeppilli P, Calabrò R. The usefulness of Doppler myocardial imaging in the study of athlete's heart and in the differential diagnosis between physiological and pathological ventricular hypertrophy. Echocardiography. 2006;23:149–157
  32. D'Andrea A, Caso P, Severino S, et al. Prognostic value of intra-left ventricular electromechanical asynchrony in patients with hypertrophic cardiomyopathy. Eur Heart J. 2006;27:1311–1318
  33. Rajiv C, Vinereanu D, Fraser AG. Tissue Doppler imaging for the evaluation of patients with hypertrophic cardiomyopathy. Curr Opin Cardiol. 2004;19:430–436
  34. Nagueh SF, McFalls J, Meyer D, et al. Tissue Doppler imaging predicts the development of hypertrophic cardiomyopathy in subjects with subclinical disease. Circulation. 2003;108:395–398
  35. Urheim S, Edvardsen T, Torp H, Angelsen B, Smiseth OA. Myocardial strain by Doppler echocardiography. Validation of a new method to quantify regional myocardial function. Circulation. 2000;102:1158–1164
  36. Voigt JU, Lindenmeier G, Werner D, et al. Strain rate imaging for the assessment of preload-dependent changes in regional left ventricular diastolic longitudinal function. J Am Soc Echocardiogr. 2002;15:13–19
  37. Cheng TO. Hypertrophic cardiomyopathy in China: from bench to bedside. Int J Cardiol. Nov. 12 2008;130:121–124
  38. Kato TS, Noda A, Izawa H, et al. Discrimination of nonobstructive hypertrophic cardiomyopathy from hypertensive left ventricular hypertrophy on the basis of strain rate imaging by tissue Doppler ultrasonography. Circulation. 2004;110:3808–3814
  39. Richand V, Lafitte S, Reant P, et al. An ultrasound speckle tracking (two-dimensional strain) analysis of myocardial deformation in professional soccer players compared with healthy subjects and hypertrophic cardiomyopathy. Am J Cardiol. 2007;100:128–132
  40. Sharma S, Elliott PM, Whyte G, et al. Utility of metabolic exercise testing in distinguishing hypertrophic cardiomyopathy from physiologic left ventricular hypertrophy in athletes. J Am Coll Cardiol. 2000;36:864–870
  41. Anastasakis A, Kotsiopoulou C, Rigopoulos A, et al. Similarities in the profile of cardiopulmonary exercise testing between patients with hypertrophic cardiomyopathy and strength athletes. Heart. 2005;91:1477–1478
  42. Godon P, Griffet V, Vinsonneau U, et al.: Athlete's heart or hypertrophic cardiomyopathy: usefulness of N-terminal pro-brain natriuretic peptide. Int J Cardiol, in press.
  43. White PD. In: Heart disease. 4th Edition. New York: MacMillan Co.; 1951;p. 611
  44. Maron BJ, Pelliccia A, Spataro A, Granata M. Reduction in left ventricular wall thickness after deconditioning in highly trained Olympic athletes. Br Heart J. 1993;69:125–128
  45. Pelliccia A, Maron BJ, De Luca R, Di Paolo FM, Spataro A, Culasso F. Remodeling of left ventricular hypertrophy in elite athletes after long-term deconditioning. Circulation. 2002;105:944–949
  46. Maron BJ, Seidman JG, Seidman CE. Proposal for contemporary screening strategies in families with hypertrophic cardiomyopathy. J Am Coll Cardiol. 2004;44:2125–2132
  47. Basavarajaiah S, Wilson M, Whyte G, Shah A, McKenna W, Sharma S. Prevalence of hypertrophic cardiomyopathy in highly trained athletes. J Am Coll Cardiol. 2008;51:1033–1039
  48. Ma JZ, Dai J, Sun B, Ji P, Yang D, Zhang JN. Cardiovascular pre-participation screening of young competitive athletes for prevention of sudden death in China. J Sci Med Sport. 2007;10:227–233
  49. Magalski A, Maron BJ, Main ML, et al. Relation of race to electrocardiographic patterns in elite American football players. J Am Coll Cardiol. 2008;51:2250–2255
  50. Bssavarajaiah S, Boraita A, Whyte G, et al. Ethnic differences in left ventricular remodeling in highly-trained athletes. Relevance to differentiating physiologic left ventricular hypertrophy from hypertrophic cardiomyopathy. J Am Coll Cardiol. 2008;51:2256–2262
  51. Pelliccia A. Differences in cardiac remodeling associated with race. Implications for pre-participation screening and the unfavorable situation of black athletes. J Am Coll Cardiol. 2008;51:2263–2265

PII: S0167-5273(08)01105-4

doi: 10.1016/j.ijcard.2008.10.015

International Journal of Cardiology
Volume 131, Issue 2 , Pages 151-155 , 9 January 2009

Article Tools